The three companies will participate in the conference organized by 3P “The Challenge of Partner Selection: The Best Travel Companion in Biopharma Development Adventure”

Next 25th September, coinciding with the celebration of Biospain, Laboratorios Leti, Genticel and Covance will share the limelight with 3P Biopharmaceuticals during the session “The Challenge of Partner Selection: The Best Travel Companion in Biopharma Development Adventure”

Thursday, September 25th (12h30-14h00 )
First Floor – Room 24

The aim of this lecture is to share with the audience how biotech companies and service providers understand each other and how to build good relationships to make drug development a success story.

This will be a great opportunity to meet biotech and pharma leaders who will share their experience in technical project management and human relationships with partners; and will provide the keys to success in this joint collaborative adventure.

Laboratorios Leti is a research-focused, independent, and family owned, biopharmaceutical company with business units: Allergy, Dermatology, Diagnostics and Immunology and Vaccines.

Genticel is a privately–owned company that develops therapeutic vaccines for women cervical cancer caused by human papillomavirus (HPV).

Covance is one of the world’s largest and most comprehensive drug development services companies. Through its lead optimization, nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today